Healthcare · Pharmaceutical expenditure
Germany's pharmaceutical expenditure in 2026 reached 2.35 % GDP of GDP—one of the highest rates globally (6 out of 197). This high share is driven by a strong pharmaceutical industry, rapid adoption of innovative drugs, and high per-capita consumption. The country ranks among the top pharmaceutical markets, reflecting both broad access to medicines and a substantial R&D base.
Data for 2026 · unit: % GDP
Position
#6 / 197
Germany world ranking
Country position on the scale from last to first place for this indicator.
DE
#6
#197#1
Trend
Change over time
Change in indicator over the available period.
1.90
1990
2.10
2000
2.20
2010
2.30
2020
2.35
2026
Values — % GDP
Comparison
Top countries by Pharmaceutical expenditure
Where Germany stands in the world ranking.
1
USUSA
2.65
2
NLNetherlands
2.60
3
NONorway
2.50
4
MCMonaco
2.40
4
NZNew Zealand
2.40
6
DEGermany
2.35
7
JPJapan
2.30
8
FRFrance
2.25
Full world rankingarrow_forward
People also search for
Other pages of the reference by this indicator.
Frequently asked questions
Pharmaceutical expenditure in Germany — how much?
Based on 2026 data — 2.35 % GDP. This is rank #6 out of 197 countries.
What is Germany's rank by Pharmaceutical expenditure?
Germany ranks #6 out of 197 countries in the world ranking by «Pharmaceutical expenditure».
How has Pharmaceutical expenditure changed in Germany?
Over the available period the indicator changed from 1.90 to 2.35 % GDP.